4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-17-044648
CIK 0001328143operating
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 5:54 PM ET
Size
7.3 KB
Accession
0001209191-17-044648
Insider Transaction Report
Form 4
MERRIWEATHER ALFRED G
Chief Financial Officer
Transactions
- Award
Common Stock
2017-07-10+18,750→ 18,750 total - Award
Stock Option (Right to Buy)
2017-07-10+112,500→ 112,500 totalExercise: $16.98Exp: 2027-07-09→ Common Stock (112,500 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest 1/4th on each of September 20, 2018, September 20, 2019, September 20, 2020 and September 20, 2021.
- [F2]The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option shall vest on June 29, 2018, and the remaining shares will vest in equal monthly installments over the next 36 months.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 5:54 PM ET
- Size
- 7.3 KB